Maja Čemažar

14.5k citations
319 papers · 10.9k · 1 hit paper · h-index 54

Impact in

  • Biotechnology top 0.01%
    • Microbial Inactivation Methods
    • Transgenic Plants and Applications
  • Immunology top 0.5%
    • Toxin Mechanisms and Immunotoxins

Papers in

    • Microbial Inactivation Methods 221
    • Transgenic Plants and Applications 36
    • Microfluidic and Bio-sensing Technologies 108
    • 3D Printing in Biomedical Research 21

Maja Čemažar

310 papers receiving 10.7k citations

Maja Čemažar's Hit Papers

Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study 2006 · 628 citations
6280+6+13Years since publication200400600

Peers

Maja Čemažar
Comparison fields: 5 of 148
  • Biotechnology 7.7k
  • Immunology 2.8k
  • Biomedical Engineering 5.0k
  • Physiology 470
  • Oncology 1.2k
Replace Gregor Serša with:
Gregor Serša Slovenia
Richard Heller United States
Lluis M. Mir France
Rafael V. Davalos United States
Marie‐Pierre Rols France
Muriel Golzio France
Abhishek D. Garg Belgium
K. Dane Wittrup United States
Leoni A. Kunz‐Schughart Germany
Rong Xiang China
Maja Čemažar relative to Gregor Serša Slovenia Gregor Serša's profile →
Citations per field
00.5×1.5×
Gregor Serša · 1×
Citations per year

Countries citing papers authored by Maja Čemažar

Since Specialization
Citations

This map shows the geographic impact of Maja Čemažar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maja Čemažar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maja Čemažar more than expected).

Fields of papers citing papers by Maja Čemažar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maja Čemažar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maja Čemažar. The network helps show where Maja Čemažar may publish in the future.

Co-authors

The 25 scholars most cited alongside Maja Čemažar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maja Čemažar Line = papers co-authored together Maja Čemažar links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 319 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study
Hit paper breakdown →
2006628
2 1998356
3 2007346
4
Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.
2001244
5
Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice.
1995238
6 1998202
7 2008172
8 2010156
9
Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients.
2000156
10 2011147
11 1998139
12 2018139
13 2010136
14 2014136
15 2018127
16 2008125
17 2015119
18 2016118
19 2008118
20 2017117

About Maja Čemažar

Maja Čemažar is a scholar working on Biotechnology, Biomedical Engineering, Molecular Biology, Immunology and Oncology, having authored 319 papers that have together received 10.9k indexed citations. Recurring topics across this work include Microbial Inactivation Methods (221 papers), Microfluidic and Bio-sensing Technologies (108 papers), Toxin Mechanisms and Immunotoxins (58 papers), Transgenic Plants and Applications (36 papers), Viral Infectious Diseases and Gene Expression in Insects (34 papers), Virus-based gene therapy research (22 papers), CRISPR and Genetic Engineering (21 papers) and 3D Printing in Biomedical Research (21 papers). The work is most often cited by research in Biotechnology (7.7k citations), Immunology (2.8k citations), Biomedical Engineering (5.0k citations), Physiology (470 citations) and Oncology (1.2k citations). Maja Čemažar has collaborated with scholars based in Slovenia, Italy and France. Frequent co-authors include Gregor Serša, Damijan Miklavčič, Z Rudolf, Marko Snoj, Simona Kranjc, Tomaž Jarm, Justin Teissié, Boštjan Markelc, Nataša Tozon and Urška Kamenšek. Their work appears in journals such as Bioelectrochemistry, The Journal of Membrane Biology, Cancers, PLoS ONE and Technology in Cancer Research & Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact